Results: 22
Falk Symposium Series.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 148, doi. 10.1159/000450593
- Publication type:
- Article
Intestinal Microbiota: Facts and Fiction.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 139, doi. 10.1159/000449095
- By:
- Publication type:
- Article
Case Report: Acute Flair of Ulcerative Colitis during Pregnancy Is Still a Major Problem.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 134, doi. 10.1159/000449094
- By:
- Publication type:
- Article
Crohn’s Disease and Intestinal Transplantation.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 127, doi. 10.1159/000449093
- By:
- Publication type:
- Article
Fecal Microbiota Transplantation in Inflammatory Bowel Disease.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 123, doi. 10.1159/000449092
- By:
- Publication type:
- Article
Mesenchymal Stromal Cell Therapy in Crohn’s Disease.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 115, doi. 10.1159/000449091
- By:
- Publication type:
- Article
Hematopoietic Stem Cell Transplantation in Crohn’s Disease: State-of-the-Art Treatment.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 107, doi. 10.1159/000449090
- By:
- Publication type:
- Article
Real-Life Efficacy, Immunogenicity and Safety of Biosimilar Infliximab.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 101, doi. 10.1159/000449089
- By:
- Publication type:
- Article
Infliximab Biosimilar (Remsima<sup>TM</sup>) in Therapy of Inflammatory Bowel Diseases Patients: Experience from One Tertiary Inflammatory Bowel Diseases Centre.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 91, doi. 10.1159/000453343
- By:
- Publication type:
- Article
Experience with Biosimilar Infliximab (Remsima<sup>®</sup>) in Norway.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 83, doi. 10.1159/000449088
- By:
- Publication type:
- Article
Does the Introduction of Biosimilars Change Our Understanding about Treatment Modalities for Inflammatory Bowel Disease?
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 74, doi. 10.1159/000449087
- By:
- Publication type:
- Article
What Can We Learn from Epidemiological Studies in Inflammatory Bowel Disease?
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 69, doi. 10.1159/000449086
- By:
- Publication type:
- Article
Combining Therapeutic Drug Monitoring with Biosimilars, a Strategy to Improve the Efficacy of Biologicals for Treating Inflammatory Bowel Diseases at an Affordable Cost.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 61, doi. 10.1159/000449085
- By:
- Publication type:
- Article
Promises and Dangers of Combination Therapy.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 56, doi. 10.1159/000449084
- By:
- Publication type:
- Article
What Should Be Done in Inflammatory Bowel Disease Patients with Prior Malignancy?
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 50, doi. 10.1159/000449083
- By:
- Publication type:
- Article
Late-Onset of Acute Severe Ulcerative Colitis: Clinical Case.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 45, doi. 10.1159/000449082
- By:
- Publication type:
- Article
Unmet Therapeutic Needs: Focus on Intestinal Fibrosis Surgical Approach: Resection, Strictureplasty and Others.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 38, doi. 10.1159/000449081
- By:
- Publication type:
- Article
Measurement of Fibrosis in Crohn’s Disease Strictures with Imaging and Blood Biomarkers to Inform Clinical Decisions.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 32, doi. 10.1159/000449080
- By:
- Publication type:
- Article
Pathogenesis of Intestinal Fibrosis in Inflammatory Bowel Disease and Perspectives for Therapeutic Implication.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 25, doi. 10.1159/000449079
- By:
- Publication type:
- Article
Improvement of a ‘Leaky’ Intestinal Barrier.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 21, doi. 10.1159/000449078
- By:
- Publication type:
- Article
Leukocyte Anti-Trafficking Strategies: Current Status and Future Directions.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 13, doi. 10.1159/000449077
- By:
- Publication type:
- Article
Anti-Cytokine Strategies beyond Anti-Tumour Necrosis Factor-α Therapy: Pathophysiology and Clinical Implications.
- Published in:
- Digestive Diseases, 2017, v. 35, n. 1/2, p. 5, doi. 10.1159/000449076
- By:
- Publication type:
- Article